|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.29 USD | +1.83% |
|
+1.48% | -30.20% |
| 06-02 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 04-27 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
Evolution of the Average Target: Daxor Corporation
Evolution of the Target Price: Daxor Corporation
Changes in Analyst Recommendations: Daxor Corporation
ffabdffb.5wiOP_A3mmsBVJtlZVQRviYnkqond-I1j0IB0iyHRjc.0FzRUaVn1Sl2HdAPKSdz7n9125JhP9pExREzvx_0DV_RZ75pqEL8BXgarw~2a23a9c6b7092203d242f6da14591761
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +10.49% | |||||
| Average | +10.49% | |||||
| Weighted average by Cap. | +10.49% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.29USD
Average target price
22.50USD
Spread / Average Target
+118.56%
High Price Target
23.00USD
Spread / Highest target
+123.41%
Low Price Target
22.00USD
Spread / Lowest Target
+113.70%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.29USD
Average target price
22.50USD
Spread / Average Target
+118.56%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Consensus Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
